FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B
Washington — U.S. wellness regulators on Tuesday approved the initially gene treatment for hemophilia, a $3.5 million just one-time therapy for the blood-clotting condition. The Food items and Drug Administration cleared Hemgenix, an IV treatment method for older people with hemophilia B, the much less common sort of the genetic condition which primarily impacts adult men. Currently, individuals obtain repeated, high priced IVs of a protein that assists blood clot and protect against bleeding. Signage for CSL Behring, a device of…